Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Risperidone in First Episode Psychosis
NCT02532491Phase 4Unknown
- Sponsor
- Fundación Marqués de Valdecilla
- Start
- May 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, risperidone in schizophrenia, psychotic disorders, sponsored by Fundación Marqués de Valdecilla. Status: unknown.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophreniapsychotic disorders
Beyond the preview
Go deeper on NCT02532491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532491.